Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Very preterm birth results in later lower platelet activation markers

Abstract

Background

Premature birth entails an adverse cardiovascular risk profile, but the underlying mechanisms are insufficiently understood. Here, we employed an unbiased cardiovascular proteomics approach to profile former very preterm-born preschoolers.

Methods

This observational study investigated differences in plasma concentrations of 79 proteins, including putative cardiovascular biomarkers between very preterm- and term-born children on average 5.5 years old (53.1% male) using multiple-reaction monitoring mass spectrometry.

Results

Very preterm-born (n = 38; median gestational age 29.6 weeks) compared to term-born (n = 26; 40.2 weeks) children featured lower plasma concentrations of platelet factor 4 (PLF4; −61.6%, P < 0.0001), platelet basic protein (CXCL7; −57.8%, P < 0.0001), and hemoglobin subunit beta (−48.3%, P < 0.0001). Results remained virtually unchanged when adjusting for complete blood count parameters, including platelet count. Conversely, whole blood hemoglobin was higher (+7.62%, P < 0.0001) in preterm-born children.

Conclusions

Very preterm birth was associated with decreased markers of platelet activation among preschoolers. These findings are consistent with reduced platelet reactivity persisting from very preterm birth to a preschool age.

Impact

  • Former very preterm-born preschoolers featured reduced levels of platelet activation markers.

  • While lower platelet reactivity in very preterm-born compared to term-born infants in the first days of life was established, it was unknown when, if at all, reactivity normalizes. The current study suggests that platelet hyporeactivity due to very preterm birth persists at least up to a preschool age.

  • “Immaturity of the hemostatic system” may be a persistent sequel of preterm birth, but larger studies are needed to investigate its potential clinical implications.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: Differences in plasma concentrations of 79 proteins between former very preterm-born and former term-born preschoolers under adjustment for age and sex.

References

  1. Bayman, E., Drake, A. J. & Piyasena, C. Prematurity and programming of cardiovascular disease risk: a future challenge for public health? Arch. Dis. Child. Fetal Neonatal Ed. 99, F510–F514 (2014).

    Article  Google Scholar 

  2. Komazec, I. O. et al. Aortic elastic properties in preschool children born preterm. Arterioscler. Thromb. Vasc. Biol. 36, 2268–2274 (2016).

    Article  Google Scholar 

  3. Stoll, B. J. et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA 314, 1039–1051 (2015).

    CAS  Article  Google Scholar 

  4. Vohr, B. R., Allan, W., Katz, K. H., Schneider, K. C. & Ment, L. R. Early predictors of hypertension in prematurely born adolescents. Acta Paediatr. 99, 1812–1818 (2010).

    Article  Google Scholar 

  5. Posod, A. et al. Former very preterm infants show an unfavorable cardiovascular risk profile at a preschool age. PLoS ONE 11, e0168162 (2016).

    Article  Google Scholar 

  6. Stock, K. et al. The impact of being born preterm or small for gestational age on early vascular aging in adolescents. J. Pediatr. 201, 49–54 (2018).

    Article  Google Scholar 

  7. Lewandowski, A. J. et al. Right ventricular systolic dysfunction in young adults born preterm. Circulation 128, 713–720 (2013).

    Article  Google Scholar 

  8. Huckstep, O. J. et al. Physiological stress elicits impaired left ventricular function in preterm-born adults. J. Am. Coll. Cardiol. 71, 1347–1356 (2018).

    Article  Google Scholar 

  9. Sola-Visner, M. Platelets in the neonatal period: developmental differences in platelet production, function, and hemostasis and the potential impact of therapies. ASH Educ. Program Book 2012, 506–511 (2012).

    Google Scholar 

  10. Markopoulou, P., Papanikolaou, E., Analytis, A., Zoumakis, E. & Siahanidou, T. Preterm birth as a risk factor for metabolic syndrome and cardiovascular disease in adult life: a systematic review and meta-analysis. J. Pediatr. 210, 69–80 (2019).

    Article  Google Scholar 

  11. Keijzer-Veen, M. G. et al. Reduced renal length and volume 20 years after very preterm birth. Pediatr. Nephrol. Berl. Ger. 25, 499–507 (2010).

    Article  Google Scholar 

  12. Crump, C., Sundquist, J., Winkleby, M. A. & Sundquist, K. Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood: National Cohort Study. BMJ 365, l1346 (2019).

    Article  Google Scholar 

  13. Brummelte, S. et al. Cortisol levels in former preterm children at school age are predicted by neonatal procedural pain-related stress. Psychoneuroendocrinology 51, 151–163 (2015).

    CAS  Article  Google Scholar 

  14. Posod, A. et al. Former very preterm infants show alterations in thyroid function at a preschool age. BioMed. Res. Int. 2017, 3805370 (2017).

    Article  Google Scholar 

  15. Fenton, T. R. & Kim, J. H. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 13, 59 (2013).

    Article  Google Scholar 

  16. Kromeyer-Hauschild, K. et al. Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr. Kinderheilkd. 149, 807–818 (2001).

    Article  Google Scholar 

  17. Posod, A. et al. Apolipoprotein profiles in very preterm and term‐born preschool children. J. Am. Heart Assoc. 8 (2019).

  18. Eden, E., Navon, R., Steinfeld, I., Lipson, D. & Yakhini, Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinform. 10, 48 (2009).

    Article  Google Scholar 

  19. Yun, S.-H., Sim, E.-H., Goh, R.-Y., Park, J.-I. & Han, J.-Y. Platelet activation: the mechanisms and potential biomarkers. BioMed. Res. Int. 2016, 9060143 (2016).

    Article  Google Scholar 

  20. Kowalska, M. A., Rauova, L. & Poncz, M. Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis. Thromb. Res. 125, 292–296 (2010).

    CAS  Article  Google Scholar 

  21. DeLoughery, T. G. Coagulation abnormalities and cardiovascular disease. Curr. Opin. Lipidol. 10, 443–448 (1999).

    CAS  Article  Google Scholar 

  22. Israels, S. J., Rand, M. L. & Michelson, A. D. Neonatal platelet function. Semin. Thromb. Hemost. 29, 363–372 (2003).

    CAS  Article  Google Scholar 

  23. Sitaru, A. G. et al. Neonatal platelets from cord blood and peripheral blood. Platelets 16, 203–210 (2005).

    CAS  Article  Google Scholar 

  24. Bednarek, F. J., Bean, S., Barnard, M. R., Frelinger, A. L. & Michelson, A. D. The platelet hyporeactivity of extremely low birth weight neonates is age-dependent. Thromb. Res. 124, 42–45 (2009).

    CAS  Article  Google Scholar 

  25. Uçar, T., Gurman, C., Arsan, S. & Kemahli, S. Platelet aggregation in term and preterm newborns. Pediatr. Hematol. Oncol. 22, 139–145 (2005).

    Article  Google Scholar 

  26. Hézard, N. et al. Unexpected persistence of platelet hyporeactivity beyond the neonatal period: a flow cytometric study in neonates, infants and older children. Thromb. Haemost. 90, 116–123 (2003).

    Article  Google Scholar 

  27. Linder, N. et al. Deposition of whole blood platelets on extracellular matrix under flow conditions in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 86, 127F–130F (2002).

    Article  Google Scholar 

  28. Jackson, S. P. The growing complexity of platelet aggregation. Blood 109, 5087–5095 (2007).

    CAS  Article  Google Scholar 

  29. Flahault, A. et al. Duration of neonatal oxygen supplementation, erythropoiesis and blood pressure in young adults born preterm. Thorax 75, 494–502 (2020).

    Article  Google Scholar 

  30. Vollsæter, M. et al. Adult respiratory outcomes of extreme preterm birth. A regional cohort study. Ann. Am. Thorac. Soc. 12, 313–322 (2015).

    Article  Google Scholar 

  31. Olivieri, N. F. Fetal erythropoiesis and the diagnosis and treatment of hemoglobin disorders in the fetus and child. Semin. Perinatol. 21, 63–69 (1997).

    CAS  Article  Google Scholar 

  32. Andrew, M., Paes, B. & Johnston, M. Development of the hemostatic system in the neonate and young infant. Am. J. Pediatr. Hematol. Oncol. 12, 95–104 (1990).

    CAS  Article  Google Scholar 

  33. Del Vecchio, A., Latini, G., Henry, E. & Christensen, R. D. Template bleeding times of 240 neonates born at 24 to 41 weeks gestation. J. Perinatol. 28, 427–431 (2008).

    Article  Google Scholar 

  34. Boudewijns, M. et al. Evaluation of platelet function on cord blood in 80 healthy term neonates using the Platelet Function Analyser (PFA-100); shorter in vitro bleeding times in neonates than adults. Eur. J. Pediatr. 162, 212–213 (2003).

    Article  Google Scholar 

  35. Saxonhouse, M. A. et al. Closure times measured by the Platelet Function Analyzer PFA-100® are longer in neonatal blood compared to cord blood samples. Neonatology 97, 242–249 (2010).

    Article  Google Scholar 

  36. Arepally, G. M. Heparin-induced thrombocytopenia. Blood 129, 2864–2872 (2017).

    CAS  Article  Google Scholar 

  37. Warkentin, T. E. et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84, 3691–3699 (1994).

    CAS  Article  Google Scholar 

  38. Amiral, J. & Vissac, A. M. Generation and pathogenicity of anti-platelet factor 4 antibodies: diagnostic implications. Clin. Appl. Thromb. Hemost. 5, S28–S31 (1999).

    CAS  Article  Google Scholar 

  39. Poncz, M., Rauova, L. & Cines, D. B. The role of surface PF4: glycosaminoglycan complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT). Pathophysiol. Haemost. Thromb. 35, 46–49 (2006).

    Article  Google Scholar 

  40. Mattioli, A. V., Bonetti, L., Zennaro, M., Ambrosio, G. & Mattioli, G. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up. Am. Heart J. 157, 589–595 (2009).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This study was supported by the Anniversary Fund of the Austrian National Bank (Project No. 14570) and the Austrian Heart Foundation, and by VASCage—Research Center on Vascular Ageing and Stroke (No. 868624). As a COMET center, VASCage is funded within the COMET program—Competence Centers for Excellent Technologies by the Austrian Ministry for Climate Action, Environment, Energy, Mobility, Innovation, and Technology, the Austrian Ministry for Digital and Economic Affairs, and the federal states Tyrol, Salzburg, and Vienna. Prof. Manuel Mayr is a British Heart Foundation (BHF) Chair Holder (CH/16/3/32406) with BHF program grant support (RG/16/14/32397). This work was supported by the National Institute of Health Research (NIHR) Biomedical Research Center based at Guy’s and St. Thomas’ National Health Service (NHS) Foundation Trust and King’s College London in partnership with King’s College Hospital.

Author information

Affiliations

Authors

Contributions

Designed the study: U.K.-K. and A.P. Obtained funding: U.K.-K. and S.K. Supervised the study: U.K.-K. Analyzed the data: R.P. Drafted the manuscript: R.P. Revised the manuscript for important intellectual content: A.P., X.Y., S.A.P., S.J.K., M.M., S.K., and U.K.-K. Performed proteomics measurements: X.Y. and S.A.P. Approved the final version of the manuscript submitted: all authors.

Corresponding author

Correspondence to Ursula Kiechl-Kohlendorfer.

Ethics declarations

Competing interests

The authors declare no competing interests.

Statement of consent

All children included in this study consented to participation orally, and written informed consent was obtained from their legal guardians.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pechlaner, R., Posod, A., Yin, X. et al. Very preterm birth results in later lower platelet activation markers. Pediatr Res 89, 1278–1282 (2021). https://doi.org/10.1038/s41390-020-1070-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41390-020-1070-8

Further reading

Search

Quick links